Proteus Digital Health
Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.
What the loss of one of the earliest and most well-known companies in the digital health space tells us about digital health and pharma.
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
The pharma company walks away with the full license for Proteus' mental health treatment adherence technology.
The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.
The sensor-embedded pill will be used to treat and monitor colorectal cancer patients receiving care at Fairview Health Services.
As the Abilify MyCite platform nears a full rollout, the companies said they are looking forward to employing the technology toward additional mental health therapies.
The two companies are planning a limited initial deployment to gather additional real-world data before a wider release.
Anthem Blue Cross and Blue Shield in Ohio has partnered with Propeller Health to provide sensor-equipped inhaler attachments to plan members with COPD.
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community.